E
Arrowhead Pharmaceuticals, Inc. ARWR
$21.33 $0.582.80% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -29.60% -100.00% --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -29.60% -100.00% --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -29.60% -100.00% --
SG&A Expenses 21.28% 13.40% 12.16% 11.37% 7.91%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 9.75% 27.99% 17.00% 30.36% 48.61%
Operating Income 6.01% 402.08% -18.21% -49.73% -71.51%
Income Before Tax -2.94% 391.05% -26.26% -58.54% -68.28%
Income Tax Expenses -- -- 103.11% -73.04% --
Earnings from Continuing Operations -2.69% 389.67% -29.43% -56.14% -67.08%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 7.13% 52.24% -15.09% 110.18% 170.06%
Net Income -2.60% 395.65% -30.27% -55.49% -65.91%
EBIT 6.01% 402.08% -18.21% -49.73% -71.51%
EBITDA 7.02% 418.32% -18.06% -50.45% -72.35%
EPS Basic 8.35% 373.31% -12.09% -34.06% -42.94%
Normalized Basic EPS 8.17% 377.99% -9.70% -35.80% -43.37%
EPS Diluted 8.67% 369.61% -12.10% -34.06% -43.44%
Normalized Diluted EPS 8.17% 375.67% -9.70% -35.80% -43.37%
Average Basic Shares Outstanding 11.95% 8.17% 16.23% 15.99% 16.07%
Average Diluted Shares Outstanding 11.95% 9.08% 16.23% 15.99% 16.07%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --